Track topics on Twitter Track topics that are important to you
Founded by James R. Von Ehr II in 1997, Zyvex is the first molecular nanotechnology company. Von Ehr’s business acumen, determination, and financial support have enabled Zyvex to become the most publicized private nanotechnology business in the world and the most highly regarded company in the field of molecular assemblers. Von Ehr himself is widely respected as one of the world’s top nanotechnology industry leaders.Zyvex’s vision is to become the leading worldwide supplier of tools, products, and services that enable adaptable, affordable, and molecularly precise manufacturing.We have spent the last few years building a world-class executive and technical team. To see a complete timeline of our progress, click here. Our state-of-the-art laboratories support our scientists and engineers with equipment not available to typical early-stage companies. We focus on some of the most fundamental core issues facing nanotechnology development and commercialization as we evolve from a technology-oriented to market-driven enterprise.
1321 North Plano Road
United States of America
LAVAL, QUEBEC -- (Marketwired) -- 07/07/17 -- Savaria Corporation (TSX: SIS) ("Savaria" or the "Corporation"), one of North America's leaders in the accessibility industry, is pleased to announce th...
TORONTO, ONTARIO -- (Marketwired) -- 08/16/17 -- Ventripoint Diagnostics Ltd. ("Ventripoint" or the "Corporation") (TSX VENTURE: VPT) announces that at its Annual General Meeting on August 14, 2017 ...
REHOVOT, Israel, Sept. 12, 2017 (GLOBE NEWSWIRE) -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drug-device combinations for central nervous system (CNS) diso...
CARLSBAD, Calif., Sept. 07, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO), a California-based clinical stage biotechnology company developing stem cell-based therapies...
VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 07/11/17 -- Advanced Proteome Therapeutics Corporation ("APC" or the "Company") (TSX VENTURE: APC)(FRANKFURT: 0E8) is pleased to report that it has co...
CARLSBAD, Calif., Sept. 20, 2017 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) ("ISCO" or "the Company"), a California-based clinical stage ...
H1 2017 operating income from ISCO’s revenue generating subsidiaries demonstrated an increase of 51% compared to its income in H1 2016, while H1 2017 revenue was $3.8 million. Edison Investment...
Founded by James R. Von Ehr II in 1997, Zyvex is the first molecular nanotechnology company. Von Ehr’s business acumen, determination, and financial support have enabled Zyvex to become the most pub...
Toshiba Medical Systems Corporation is a leading worldwide provider of medical diagnostic imaging systems and comprehensive medical solutions, such as CT, X-ray and vascular, ultr...
Bruker Corporation is a leading provider of high-performance scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analy...
NEC Corporation of America (NEC) is a leading technology integrator providing solutions that improve the way people work and communicate. NEC delivers integrated Solutions for Soc...
Hot Spring Spas is the worldâs leading brand of hot tubs and is sold through a network of more than 700 independent dealers throughout North America and 70 countries around t...
We have published hundreds of Zyvex Corporation news stories on BioPortfolio along with dozens of Zyvex Corporation Clinical Trials and PubMed Articles about Zyvex Corporation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Zyvex Corporation Companies in our database. You can also find out about relevant Zyvex Corporation Drugs and Medications on this site too.